Indian Pharmacopoeia, 2007

Indian Pharmacopoeia, 2007 PDF Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 264

Get Book Here

Book Description

Indian Pharmacopoeia, 2007

Indian Pharmacopoeia, 2007 PDF Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 264

Get Book Here

Book Description


Indian Pharmacopoeia 2010

Indian Pharmacopoeia 2010 PDF Author: Government of India. Ministry of Health & Family Welfare
Publisher:
ISBN:
Category :
Languages : en
Pages :

Get Book Here

Book Description


The Unani Pharmacopoeia of India

The Unani Pharmacopoeia of India PDF Author:
Publisher:
ISBN:
Category : Botany, Medical
Languages : en
Pages : 284

Get Book Here

Book Description


The Ayurvedic Pharmacopoeia of India

The Ayurvedic Pharmacopoeia of India PDF Author:
Publisher:
ISBN:
Category : Medicine, Ayurvedic
Languages : en
Pages : 502

Get Book Here

Book Description


Countering the Problem of Falsified and Substandard Drugs

Countering the Problem of Falsified and Substandard Drugs PDF Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309269393
Category : Medical
Languages : en
Pages : 377

Get Book Here

Book Description
The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.

Martindale

Martindale PDF Author: Sean C. Sweetman
Publisher:
ISBN: 9780853697046
Category : Medical
Languages : en
Pages : 3335

Get Book Here

Book Description
This is thirty-fifth edition of Martindale, which provides reliable, and evaluated information on drugs and medicines used throughout the world. It contains encyclopaedic facts about drugs and medicines, with: 5,500 drug monographs; 128,000 preparations; 40,700 reference citations; 10,900 manufacturers. There are synopses of disease treatments which enables identification of medicines, the local equivalent and the manufacturer. It also Includes herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicines. Based on published information and extensively referenced

INDIAN PHARMACOPOEIA 2018 (ADDENDUM 2021).

INDIAN PHARMACOPOEIA 2018 (ADDENDUM 2021). PDF Author:
Publisher:
ISBN: 9788193721421
Category :
Languages : en
Pages :

Get Book Here

Book Description


The International Pharmacopoeia

The International Pharmacopoeia PDF Author: World Health Organization
Publisher: World Health Organization
ISBN: 924156301X
Category : Medical
Languages : en
Pages : 1526

Get Book Here

Book Description
The International Pharmacopoeia contains a collection of recommended methods for analysis and quality specifications for pharmaceutical substances, excipients and products. This new edition consolidates the texts of the five separate volumes of the third edition and includes new monographs for antiretroviral substances (didanosine, indinavir sulfate, nelfinavir mesilate, nevirapine, ritonavir, saquinovir, and saquinovir mesilate) adopted by the WHO Expert Committee on Specifications for Pharmaceutical Preparations in October 2004. It includes some additions and amendments to the general notices of the Pharmacopoeia, as well as some changes to its layout and format. Volume one contains monographs for pharmaceutical substances A to O and the General Notices; and volume two contains monographs for pharmaceutical substances P to Z, together with those for dosage forms and radiopharmaceutical preparations, the methods of analysis and reagents.

WHO Monographs on Selected Medicinal Plants

WHO Monographs on Selected Medicinal Plants PDF Author: World Health Organization
Publisher: World Health Organization
ISBN: 9789241545372
Category : Health & Fitness
Languages : en
Pages : 392

Get Book Here

Book Description
This is the second volume in a series of monographs which are intended to promote information exchange and international harmonised standards for the quality control and use of herbal medicines. It contains scientific information on 30 selected plants, and each entry includes a pharmacopoeial summary for quality assurance purposes, information on its clinical application and sections on contraindications, pharmacology, safety issues, and dosage forms. It provides two cumulative indexes with entries in alphabetical order by plant name and according to the plant material of interest.

Indian Pharmacopoeia 2014 (4 Vol Set)

Indian Pharmacopoeia 2014 (4 Vol Set) PDF Author: Indian Pharmacopoeia Commission
Publisher:
ISBN: 9789381238073
Category :
Languages : en
Pages :

Get Book Here

Book Description
The seventh edition of the Indian Pharmacopoeia (IP 2014) is published by the Indian Pharmacopoeia Commission (IPC) on behalf of the Government of India, Ministry of Health & Family Welfare. The Indian Pharmacopoeia (IP) is published in fulfilment of the requirements of the Drugs and Cosmetics Act, 1940 and Rules thereunder. It prescribes the standards for drugs produced and/or marketed in India and thus contributes in the control and assurance of the quality of the medicines. The standards of this pharmacopoeia are authoritative and legally enforceable. It intends to help in the licensing of manufacturing, inspection and distribution of medicines. IP is published in continuing pursuit of the mission of IPC to improve the health of the people through ensuring the quality, safety and efficacy of medicines. The Commission has been receiving significant inputs from regulatory, industrial houses, academic institutions, national laboratories, individual scientists and others. Publication of IP at regular and shorter intervals is one of the main mandates of the Commission. The seventh edition of Indian Pharmacopoeia is published in accordance with the principles and designed plan decided by the Scientific Body of the IPC. To establish transparency in setting standards for this edition the contents of new monographs, revised appendices and other informations have been publicized on the website of the IPC, besides following conventional approach of obtaining comments. The feedback and inputs were reviewed by the relevant Expert Committee to ensure the feasibility and practicability of the standards and methods revised. The principle of "openness, justice and fairness" is kept in mind during compiling and editing the contents of this edition. The Indian Pharmacopoeia 2014 is presented in four volumes. The scope of the Pharmacopoeia has been extended to include products of biotechnology, indigenous herbs and herbal products, veterinary vaccines